Partner Judy Waltz was quoted in “Improper Hospital Payments May Have Cost Medicare $426M,” published in Bloomberg BNA, about a recent Department of Health and Human Services Office of Inspector General report which identified 465 hospital cost reports that should have been referred for outlier payment reconciliation or were referred, but never reconciled.
“I think the numbers identified here do serve as a reminder that there are some reimbursement implications to hospitals and health system cost reports, even though most of the payments come from prospective payment systems,” Waltz said.
“I think the numbers identified here do serve as a reminder that there are some reimbursement implications to hospitals and health system cost reports, even though most of the payments come from prospective payment systems,” Waltz said.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”